Progenity, Inc., an innovative biotechnology company, announced the closing of its previously announced underwritten public offering of 40,000,000 shares of its common stock and warrants to purchase up to 40,000,000 shares of its common stock, at a public offering price of $1.00 per share and associated warrant.
August 24, 2021
· 2 min read